Literature DB >> 15000444

Hyperosmolar non-ketotic diabetic syndrome associated with rhabdomyolysis and acute renal failure: a case report and review of literature.

T Ka1, S Takahashi, Z Tsutsumi, Y Moriwaki, T Yamamoto, M Fukuchi.   

Abstract

A 64-year-old man was admitted to our hospital because of general fatigue and drowsiness. On admission, a physical examination disclosed dehydration and a laboratory investigation revealed the following values: plasma glucose, 1309 mg/dl; serum sodium, 160 mmol/l; potassium, 3.0 mmol/l; urea nitrogen, 65 mg/dl; creatinine, 2.73 mg/dl; and plasma osmolarity, 403 mOsm/kg. Urine ketone bodies were negative. A diagnosis of hyperosmolar non-ketotic diabetic syndrome was made, and hydration with an infusion of hypotonic saline (0.45%) and insulin therapy were immediately started. However, despite adequate rehydration and correction of blood glucose, his serum creatinine level increased to 3.1 mg/dl, while oliguria and myoglobinuria developed on the 4th hospital day, with serum creatine kinase increasing up to a maximum level of 16,749 IU/l, suggesting rhabdomyolysis. A final diagnosis of hyperosmolar non-ketotic diabetic syndrome associated with rhabdomyolysis and acute renal failure was made. His renal function gradually improved without hemodialysis, though acute renal failure due to rhabdomyolysis with hyperosmolar non-ketotic diabetic syndrome can sometimes be fatal. This rare case is presented along with a review of literature.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15000444

Source DB:  PubMed          Journal:  Diabetes Nutr Metab        ISSN: 0394-3402


  9 in total

1.  Elevated extracellular glucose and uncontrolled type 1 diabetes enhance NFAT5 signaling and disrupt the transverse tubular network in mouse skeletal muscle.

Authors:  Erick O Hernández-Ochoa; Patrick Robison; Minerva Contreras; Tiansheng Shen; Zhiyong Zhao; Martin F Schneider
Journal:  Exp Biol Med (Maywood)       Date:  2012-09-10

2.  Diabetic Myopathy and Mechanisms of Disease.

Authors:  Erick O Hernández-Ochoa; Camilo Vanegas
Journal:  Biochem Pharmacol (Los Angel)       Date:  2015-10-31

3.  Context-dependent regulation of Th17-associated genes and IFNγ expression by the transcription factor NFAT5.

Authors:  Maria Alberdi; Marcos Iglesias; Sonia Tejedor; Ramón Merino; Cristina López-Rodríguez; Jose Aramburu
Journal:  Immunol Cell Biol       Date:  2016-08-01       Impact factor: 5.126

4.  Rhabdomyolysis-Induced Acute Kidney Injury in Diabetic Emergency: Underdiagnosed and an Important Association to Be Aware of.

Authors:  Ami Amin; Bhavika Gandhi; Steven Torre; Alireza Amirpour; Jennifer Cheng; Mayurkumar Patel; Mohammad A Hossain
Journal:  Case Rep Med       Date:  2018-10-31

Review 5.  Regulation of Inflammatory Functions of Macrophages and T Lymphocytes by NFAT5.

Authors:  Jose Aramburu; Cristina López-Rodríguez
Journal:  Front Immunol       Date:  2019-03-20       Impact factor: 7.561

6.  Improvement in renal prognosis with prompt hemodialysis in hyperosmolar hyperglycemic state-related rhabdomyolysis: A case report.

Authors:  I-Wen Chen; Cheng-Wei Lin
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

7.  Analysis of the transcriptional activity of endogenous NFAT5 in primary cells using transgenic NFAT-luciferase reporter mice.

Authors:  Beatriz Morancho; Jordi Minguillón; Jeffery D Molkentin; Cristina López-Rodríguez; Jose Aramburu
Journal:  BMC Mol Biol       Date:  2008-01-25       Impact factor: 2.946

8.  The transcription factor NFAT5 is required for cyclin expression and cell cycle progression in cells exposed to hypertonic stress.

Authors:  Katherine Drews-Elger; M Carmen Ortells; Anjana Rao; Cristina López-Rodriguez; Jose Aramburu
Journal:  PLoS One       Date:  2009-04-21       Impact factor: 3.240

9.  The Corrected Serum Sodium Concentration in Hyperglycemic Crises: Computation and Clinical Applications.

Authors:  Todd S Ing; Kavitha Ganta; Gautam Bhave; Susie Q Lew; Emmanuel I Agaba; Christos Argyropoulos; Antonios H Tzamaloukas
Journal:  Front Med (Lausanne)       Date:  2020-08-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.